Abstract
Thyroid nodule biopsy can have inadequate or indeterminate results and frequently requires re-biopsy. This study was done using a 14-gauge large core needle (LCNB) for initial biopsy of suspicious nodules to evaluate: 1) safety and efficacy; 2) reduction of non-diagnostic (ND) and uncertain (AUS/FLUS) results; and 3) use of rapid on-site evaluation (ROSE) by a cytopathologist. A total of 308 thyroid biopsies of a solitary (180) or largest (128) nodule were done with ultrasound guidance using a 14-gauge large core needle. The patients were divided into two sequential cohort groups: the first group of 152 patients. (49%) with LCNB biopsy cores judged adequate by the interventionalist and the second group 156 patients. (51%) using rapid on-site evaluation (ROSE) by a cytopathologist. The two groups were matched for age range and average (22-82 years, avg. 56 years in group one and 21-84, avg. 57 years in group two) and nodule size (1-4 cm in group one and 1-4.8 cm in group two, avg. 1.8 cm each). Malignant biopsy results and AUS/FLUS and FN/SFN were compared to surgical pathology and benign results to follow-up. LCNB biopsy malignancy rate was 26.9% in the first group and 28.1% in the second group. In the first group, two cases interpreted as atypical cells (category 3 AUS/FLUS) and were upgraded to malignancy at surgery. In the second group, one lesion was category 4 FN/SFN and upgraded to malignant at final surgical histology. The rest showed concordance with surgical pathology. Sensitivity was 98.8%, in the first group and 99.4% in the second group. No false positives were recorded, yielding a specificity of 100% in both cohort groups. Accuracy was 98.0% in the first group and 98.7% in the second group. No unsatisfactory (category 1) results were seen. Benign results were followed for an average of 3.8 years (1-9 years.), no benign cases developed malignancy. No cases of needle tract seeding or laryngeal nerve injury were seen. 1. LCNB can be performed safely and effectively. 2. LCNB reduces non-diagnostic and uncertain category diagnoses in the initial biopsy of suspicious thyroid nodules. 3. Rapid onsite evaluation (ROSE) cytopathology decreases the number of cores needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.